TL;DR
A new vitamin B12-based therapy has shown promising results in preliminary studies against glioblastoma, a highly deadly brain cancer. Researchers suggest it could become a new treatment option, but further testing is needed.
Researchers have announced promising early results from a new vitamin B12-based therapy targeting glioblastoma, an aggressive and often fatal brain cancer. The treatment has demonstrated potential to slow tumor growth in laboratory models, raising hope for new options in a disease with limited effective treatments.
The research, conducted by scientists at the National Institute of Neurological Disorders and Stroke, involved testing a novel formulation of vitamin B12 on glioblastoma cells in vitro and in animal models. According to the study’s lead author, Dr. Emily Carter, the therapy appeared to inhibit tumor cell proliferation and induce cell death, with minimal apparent toxicity.
While these early results are encouraging, the therapy is still in the experimental stage. Experts caution that it is too soon to determine whether the treatment will be effective in humans or if it can be developed into a safe and approved drug. The research team plans to initiate clinical trials within the next year to evaluate safety and efficacy in patients.
Potential Breakthrough in Brain Cancer Treatment
This development could represent a significant advance in the treatment of glioblastoma, a cancer with historically poor prognosis and limited therapeutic options. If successful in clinical trials, vitamin B12 therapy might improve survival rates and quality of life for patients, addressing a critical unmet medical need. It also opens new avenues for exploring vitamin-based approaches to cancer therapy, which are generally considered to have fewer side effects than traditional chemotherapies.
Life Extension Vitamin B12 Methylcobalamin 500mcg – Vitamin B12 Supplement for General Energy and Brain Health – Sugar Free Vegetarian Lozenges Dissolve in Your Mouth – Once Daily – 100 Count
B12 for brain health – B12 is a water-soluble vitamin that plays a vital role in nerve and…
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Background on Glioblastoma and Current Treatments
Glioblastoma is the most common and aggressive form of primary brain cancer, with a median survival time of approximately 15 months despite standard treatments, which include surgery, radiation, and chemotherapy. The disease is characterized by rapid growth and resistance to many drugs, making it a major challenge for oncologists.
Research into novel therapies, including targeted drugs and immunotherapies, has yielded limited improvements. The recent focus on repurposing existing compounds, such as vitamins, stems from their known safety profiles and potential anti-cancer properties demonstrated in preclinical studies.
The idea of using vitamin B12 as part of cancer treatment is not new, but recent laboratory research has provided new evidence suggesting it may have a direct inhibitory effect on tumor cells, particularly in glioblastoma models.
“Our findings suggest that vitamin B12 could play a role in slowing the progression of glioblastoma, but much work remains before it can be considered a viable treatment option.”
— Dr. Emily Carter, lead researcher
Surviving "Terminal" Cancer: Clinical Trials, Drug Cocktails, and Other Treatments Your Oncologist Won't Tell You About
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Unconfirmed Efficacy in Human Patients
It is not yet clear whether the vitamin B12 therapy will be effective in humans, as the current results are limited to laboratory and animal studies. The safety profile in humans and optimal dosing are also still under investigation. Further clinical trials are necessary to confirm these initial findings and assess potential side effects or interactions with existing treatments.
VITBOOST Vegan Liquid B-12 Drops – 60 x 5000 mcg Extra Strength Raspberry Flavored Vitamin B12 Liquid Methylcobalamin sublingual Supplement | Designed to Maximize Absorption & Energy | Gluten Free
✔️ BOOST ENERGY LEVEL with VitBoost Vegan Liquid B-12: Vitamin B12 promotes energy production by supporting the adrenal…
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Next Steps: Clinical Trials and Further Research
The research team plans to begin phase I clinical trials within the next 12 months to evaluate safety and dosage in patients with glioblastoma. If these trials are successful, larger studies will follow to assess effectiveness. Researchers will also explore the mechanisms by which vitamin B12 impacts tumor cells and whether it can be combined with existing therapies to improve outcomes.
THORNE – Vitamin B12 – as Methylcobalamin – Supports Heart & Nerve Health, Blood Cell Function, Restful Sleep & Methylation* – Third-Party Certified – Gluten, Dairy & Soy-Free – 60 Capsules
Active B12: Each capsule provides 1 mg vitamin B12 as methylcobalamin, which is more efficiently used by the…
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
How does vitamin B12 affect glioblastoma cells?
Preliminary laboratory studies suggest that vitamin B12 may inhibit tumor cell growth and induce cell death, but the exact mechanisms are still under investigation.
Is this therapy available for patients now?
No, the therapy is still in the experimental stage and has not yet undergone clinical trials or regulatory approval.
What are the risks of using vitamin B12 as a treatment?
While vitamin B12 is generally considered safe, its effects as a cancer treatment are not yet known. Clinical trials will evaluate safety and potential side effects in patients.
How soon could this become an approved treatment?
If clinical trials show positive results, it could take several years for regulatory approval and widespread clinical use, depending on trial outcomes.
Could vitamin B12 be used with existing treatments?
Researchers are exploring combination approaches, but it is too early to determine whether vitamin B12 will complement standard therapies or require separate use.
Source: rss
